Affiliation:
1. Department of Neurology Medical University of Warsaw Warsaw Poland
2. Department of Biochemistry Medical University of Warsaw Warsaw Poland
3. Department of Infectious and Tropical Diseases and Hepatology Medical University of Warsaw Warsaw Poland
Abstract
AbstractIntroductionHepcidin is a peptide associated with controlling the distribution of iron in tissues. Growing interest is linked with its impact on neurodegenerative diseases, as disruption of the iron regulation may be considered an initiatory element of pathological protein accumulation. The possible impact of hepcidin was not previously sufficiently explored in progressive supranuclear palsy (PSP).MethodsTwelve patients with PSP–Richardson's syndrome (PSP–RS), 12 with PSP‐Parkinsonism Predominant (PSP‐P), and 12 controls were examined using Unified Parkinson's Disease Rating Scale—III part (UPDRS‐III) in OFF stage and analyzed in the context of hepcidin levels in the serum.ResultsThe work revealed increased levels of hepcidin in PSP–RS when compared to PSP‐P and controls. Moreover, hepcidin was found to be negatively correlated with UPDRS‐III results in PSP–RS, whereas positively in PSP‐P.ConclusionThe work may suggest a possible impact of hepcidin in PSP, possibly differing depending on its subtype.
Funder
Warszawski Uniwersytet Medyczny